Relationship between psychopathological comorbidity and outcomes variables in-treatment cocaine dependent subject in therapeutic community

Authors

  • Esperanza Vergara-Moragues Departamento de Educación. Universidad Internacional de la Rioja (UNIR). Centro de Investigación Mente, Cerebro y Comportamiento (CIMCYC). Universidad de Granada. Facultad de Psicología, Universidad de Granada, Campus de Cartuja S/N, 18071 Granada, España. Tel.: +34 958242948; fax: +34 958243749.
  • Francisco González-Saiz Unidad de Salud Mental Comunitaria Villamartín. UGC Salud Mental Hospital de Jerez (Cádiz).
  • Oscar Lozano-Rojas Departamento de Psicología Clínica, Experimental y Social. Universidad de Huelva.
  • Fermín Fernández Calderón Agencia de Servicio Sociales y Dependencia de Andalucía.
  • Antonio Verdejo García Instituto de Neurociencia F. Olóriz. Universidad de Granada.
  • Patricia Betanzos Espinosa Centro de Investigación Mente, Cerebro y Comportamiento (CIMCYC). Universidad de Granada.
  • Izaskun Bilbao Acedos Agencia de Servicio Sociales y Dependencia de Andalucía.
  • Miguel Pérez García Centro de Investigación Mente, Cerebro y Comportamiento (CIMCYC). Universidad de Granada.

DOI:

https://doi.org/10.20882/adicciones.60

Keywords:

Cocaine, therapeutic community, treatment, psychopathology, substance use disorder

Abstract

Over the last years, the therapeutic community treatment with people who have cocaine problems and psychopathological comorbidity has been increasing and it is important to know more about the success of these treatments. The aim of this paper is to study the psychopathological profile of cocaine-dependent patients and its association with outcome variables. It is interviewed by the Psychiatric Research Interview for Substance and Mental Disorders (PRISM-IV) and the Conners’ Adult ADHD Diagnostic Interview for DSM-IV (CAADID) a total sample of 218 patients who sought treatment at any of the six public therapeutics community of Andalusia (Spain). The results show that the retention rate after three months of 68.3% (149), 43.5% that leaves the resource with a therapeutic discharge and 52.8% with clinically significant changes. Besides, the 57.8% have psychopathological comorbidity. Finally, there is a higher treatment success (measured by days of stay, type of discharge and therapeutic community outcome clinical impression) among people without psychopathological comorbidity. These data show the need to adapt the therapeutic communities to treat people with comorbid psychopathology and, thus, improve therapeutic success.

References

Agostini, V., Nunes, E., Stewart, J. W. y Quitkin, F. M. (1991). Patient

factors related to early attrition from an outpatient cocaine research clinic: A preliminary report. International Journal of the Addictions, 26, 327–334.

Arenas, F., del Valle, M., López, R., Martín, J. y Tirado, P. (2003). Programa de Intervención. Comunidad Terapéutica en Andalucía. Sevilla: Consejería de Asuntos Sociales. Comisionado para las Drogodependencias. Junta de Andalucía.

Alterman, A. I., Rutherford, M. J. , Cacciola, J. S., McKay, J. R. y Woody,G.

E.. (1996). Response to Methadone Maintenance and Counseling in Antisocial Patients with and without Major Depression. Journal of Nervous and Mental Disease, 184, 695-670.

Broome, K. M., Flynn, P. M. y Simpson, D. D. (1999). Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research, 34, 791–806.

Bunt, G., Muehlbach, B. y Moed, C. (2008). The therapeutic Community:

an international perspective. Substance Abuse, 29, 81-87. doi: 10.1080/08897070802218844.

Condelli, W. S. (1994). Domains of variables for understanding and

improving retention in therapeutic communities. International Journal of the Addictions, 29, 593-607.

Condelli, W. S. y Hubbard, R. L. (1994). Relationship between time spent

in treatment and client outcomes from therapeutic communities. Journal Substance Abuse Treatment, 11, 25-33.

Condelli, W.S. y Dunteman, G.H. (1993). Issues to consider when predicting retention in therapeutic communities. Journal of Psychoactive Drugs, 25, 239-244.

Condelli, WS. y De Leon, G. (1993). Fixed and Dynamic Predictors of

Client Retention in therapeutic communities. Journal Substance Abuse Treatment, 10, 11-16.

Conners, C. K. , Erhardt, D. y Sparrow, E. (1999). Conners adult ADHD

rating scales. North Tonawanda, Nueva York: Multi-Health Systems.

Darke, S., Campbell, G. y Popple, G. (2012). Retention, early dropout and

treatment completion among therapeutic community admissions. Drug and Alcohol Review, 31, 64–71. doi: 10.1111/j.1465-3362.2011.00298

De Leon, G., Sacks, S., Staines, G. y McKendrick, K. (2000). Modified

therapeutic community for homeless mentally ill chemical abusers: treatment outcomes. American Journal of Drug and Alcohol Abuse, 26,461–480.

De Leon, G. (1991). Retention in drug-free therapeutic communities. En R.W. Pickens, C.G. Leukefeld y C.R.Schuster (Eds.), Improving drug abuse treatment. NIDA Research Monograph Series, nº 106.

Rockville, MD: US. Department of Health and Human Services. Dekel, R., Benbenishty, R., y Amram, Y. (2004). Therapeutic communities for drug addicts: prediction of long-term outcomes. Addictive Behaviors, 29, 833-837.

European Monitoring Centre for Drugs and Drug Addiction (2011). Annual Report 2009: Annual report on the state of the drugs problem in Europe. Recuperado de: http://www.emcdda.europa.eu/publications/annual-report/2011.

Falck, R.S., Wang, J., Siegal, H.A. y Carlson, R.G. (2004). The prevalence

of psychiatric disorder among a community sample of crack cocaine users: an exploratory study with practical implications. Journal of Nervous and Mental Disease ,192, 503-507.

Fernández-Hermida, J. R. , Secades-Villa, R. , Fernández-Ludeña , J. J. y Marina-González, P, A. (2002). Effectiveness of a therapeutic community treatment in Spain: a long-term follow-up study. European Addiction Research, 8, 22-29.

Gossop, M., Marsden, J., Stewart, D., y Rolfe, A. (1999).Treatment retention and 1 year outcomes for residential programmes in England. Drug Alcohol & Dependence, 57, 89–98.

Greenfield, L., Burgdorf, K., Chen, X., Porowsk, A., Roberts, T., y Herrell, J. (2004). Effectiveness of long-term residential substance abuse treatment for women: findings from three national studies. American Journal of Drug and Alcohol Abuse, 30, 537–550.

Gilchrist, G., Langohr, K., Fonseca, F., Muga, R. y Torrens, M. (2012). Factors associated with discharge against medical advide from and alcohol and drug inpatient detoxification unit in Barcelona between 1993 and 2006. Heroin Addiction and Related Clinical Problems, 14, 35-44.

Hasin, D., Trautman, K., Miele, G., Samet, S., Smith, M., y Endicott, J. (1996). Psychiatric Research Interview for Substance and Mental Disorders (PRISM): Reliability for substance abusers. American Journal of Psychiatry, 153, 1195-1201.

Herrero, M.J., Domingo-Salvany, A., Brugal, M. T., Torrens, M. y Itinere

Investigators. (2011). Incidence of psychopathology in a cohort of young heroin and/or cocaine users. Journal of Substance Abuse Treatment, 41, 55-63. doi: 10.1016/j.jsat.2011.01.013

Joe, G.W., Simpson, D.D. y Broome, K. M. (1998). Effects of readiness for drug abuse treatment on client retention and assessment of process. Adicction, 93, 1177-1190.

Levin, F. R., Evans, S. M., Vosburg, S. K., Horton, T., Brooks, y D., Ng, J.

(2004). Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addiction Behaviour, 29, 1875–1882.

Lewis, B.J. y Ross, R. (1994). Retention in therapeutic communities: challenges for the nineties. En F. M. Tims., G. De Leon y N. Jainchill (Eds.), Therapeutic community: advances in research and application. NIDA Research Monograph 144.

Maglione, M., Chao, B. y Anglin, D. (2000). Residential treatment of

methamphetamine users: correlates of drop-out from the California Alcohol and Drug Data Systems (CADDS), 1994–1997. Addiction Research, 8, 65–79.

Malivert, M., Fatséas, M., Denis, C., Langlois, E. y Auriacombe, M. (2012).

Effectiveness of therapeutic communities: a systematic review. European Addiction Research, 18, 1-11. doi: 10.1159/000331007

Messina, N., Wish, E. y Nemes, S. (2000). Predictors of treatment

outcomes in men and women admitted to a therapeutic community. American Journal of Drug and Alcohol Abuse, 26,207–227.

Mulder, R., Frampton, C. M., Peka, H., Hampton, G. y Marsters, T. (2009). Predictors of 3-month retention in a drug treatment therapeutic community. Drug and Alcohol Review, 28, 366-371. doi: 10.1111/j.1465-3362.2009.00050.x

Nielsen, AL. y Scarpitti, FR. (2002). Predicting Retention in a Therapeutic

Community for Incarcerated Substance Abusers Journal of Offender Rehabilitation, 34, 47-65.

Ramos-Quiroga, J. A., Bosch, R., Richarte, V., Velero, S., Gómez-Barros, N., Nogueira, M., Palomar, G., Corrales, M., Sáez-Francàs, N., Corominas,

M., Real, A., Vidal, R., Chalita, P. J. y Casas, M. (2012). Validación de criterio y concurrente de la versión española de la Conners Adult ADHD Diagnostic Interview for DSM-IV. Revista de Psiquiatría y Salud Mental, 5, 229-235. doi: 10.1016/j.rpsm.2012.05.004.

Sacks, S., McKendrick, K., Sacks, J. Y. y Cleland, C. M. (2010). Modified

therapeutic community for co-occurring disorders: single investigator meta analysis. Substance Abuse, 31, 146-161. doi: 10.1080/08897077.2010.495662

Sacks, S., Banks, S., McKendrick, K., y Sacks, J. Y. (2008a). Modified

therapeutic community for co-occurring disorders: a summary of four studies. Journal Substance and Abuse Treament, 34, 112-122.

Sacks, S., McKendrick, K., Sacks, J. Y., Banks, S., y Harle, M. (2008b).

Enhanced outpatient treatment for co-occurring disorders: main outcomes. Journal Substance and Abuse Treament, 34, 48-60.

Secades-Villa, R. y Fernández-Hermida, J. R. (2000). Cómo mejorar las

tasas de retención en los tratamientos de drogodependenicas. Adicciones, 12, 353-363.

Secades-Villa, R. y Benavente, M. (2000). Predictores de la retención en

una Comunidad Terapéutica para Drogodependientes. Adicciones, 12, 365-371.

Torrens, M., Serrano, D., Astals, M., Perez-Dominguez, G., y Martin Santos, R. (2004). Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. American Journal of Psychiatry,161, 1231-1237.

Tull, M. T. y Gratz, K. L. (2012). The impact of borderline personality disorder on residential substance abuse treatment dropout among men. Drug Alcohol & Dependence, 1, 121, 97-102. doi: 10.1016/j. drugalcdep.2011.08.014

Van Stelle, K. R., Blumer, C. y Moberg, D. P. (2004).Treatment retention

of dually diagnosed offenders in an institutional therapeutic community. Behavioral Sciences & The Law, 22, 585-97.

Vergara-Moragues, E., González-Saiz, F., Lozano Rojas, O. M., Betanzos

Espinosa, P., Fernández Calderón, F., Bilbao Acedos, I., Pérez García,

M., Verdejo-García, A. (2012). Psychiatric Comorbidity in cocaine

users treated in therapeutic community: Substance-induced versus

independent disorders. Psychiatry Research, 200, 734-41. doi: 10.1016/j.psychres.2012.07.043

Vergara-Moragues, E. (2010). Comorbilidad psicopatológica en pacientes

con dependencia de cocaína tratados en comunidad terapéutica. Tesis Doctoral en Psicología. Granada: Facultad de Psicología. Universidad de Granada.

Wise, B. K., Cuffe, S. P. y Fischer, T. (2001). Dual diagnosis and successful

participation of adolescents in substance abuse treatment. Journal of Substance Abuse Treatment, 21, 161–165.

Downloads

Published

2013-06-01

Issue

Vol. 25 No. 2 (2013)

Section

Originals